Clinical Trial Update: Implication of Metformin Plus Aromatase Inhibitor in Obese Postmenopausal Breast Cancer Women [Phase 2]

View source ↗

Summary

Phase 2 trial update exploring metformin in combination with an aromatase inhibitor for obese postmenopausal breast cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Tanta University | Conditions: Metformin, Breast Cancer | Phase 2 | Status: COMPLETED